|
BZW2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.361800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.94870000000047E-05 |
| Normal-vs-Stage2 |
3.080500E-03 |
| Normal-vs-Stage3 |
3.96310000000399E-05 |
| Normal-vs-Stage4 |
4.507200E-01 |
| Stage1-vs-Stage2 |
9.993800E-01 |
| Stage1-vs-Stage3 |
2.697600E-01 |
| Stage1-vs-Stage4 |
2.583000E-01 |
| Stage2-vs-Stage3 |
4.588200E-01 |
| Stage2-vs-Stage4 |
2.593800E-01 |
| Stage3-vs-Stage4 |
2.269000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.461200E-01 |
| Normal-vs-AfricanAmerican |
5.298800E-01 |
| Normal-vs-Asian |
8.611800E-01 |
| Caucasian-vs-AfricanAmerican |
5.347800E-01 |
| Caucasian-vs-Asian |
5.168800E-01 |
| AfricanAmerican-vs-Asian |
6.423400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.438220E-04 |
| Normal-vs-Female |
9.505800E-01 |
| Male-vs-Female |
3.975400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.619800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.576400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.559000E-04 |
| Normal-vs-Age(81-100Yrs) |
2.216000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.366400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.104790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.329850E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.024600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.439600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.196400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.058800E-01 |
| Normal-vs-Grade 2 |
1.201400E-04 |
| Normal-vs-Grade 3 |
9.559400E-01 |
| Normal-vs-Grade 4 |
1.892750E-01 |
| Grade 1-vs-Grade 2 |
4.966200E-01 |
| Grade 1-vs-Grade 3 |
6.497200E-01 |
| Grade 1-vs-Grade 4 |
8.692400E-01 |
| Grade 2-vs-Grade 3 |
3.629200E-01 |
| Grade 2-vs-Grade 4 |
8.005800E-02 |
| Grade 3-vs-Grade 4 |
6.929200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.45789999464563E-08 |
| Normal-vs-ccB subtype |
5.216300E-02 |
| ccA subtype-vs-ccB subtype |
2.56910000051569E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.50910000000071E-05 |
| Normal-vs-N1 |
7.932200E-01 |
| N0-vs-N1 |
2.091200E-01 |
|
|
